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It is well known from epidemiology that values of indices describing physiological state in a given age may inﬂuence human
morbidity and mortality risks. Studies of connection between aging and life span suggest a possibility that dynamic properties of
age trajectories of the physiological indices could also be important contributors to morbidity and mortality risks. In this paper we
usedataonlongitudinalchangesinbodymassindex,diastolicbloodpressure,pulsepressure,pulserate,bloodglucose,hematocrit,
and serum cholesterol in the Framingham Heart Study participants, to investigate this possibility in depth. We found that some
of the variables describing individual dynamics of the age-associated changes in physiological indices inﬂuence human longevity
and exceptional health more substantially than the variables describing physiological state. These newly identiﬁed variables are
promising targets for prevention aiming to postpone onsets of common elderly diseases and increase longevity.
1.Introduction
Individual age trajectories of physiological indices result
from complicated interplay among genetic and environmen-
tal (including behavioral) factors taking place during the
aging process and so, they may diﬀer substantially among
individuals in cohort. Despite this fact the average age
trajectoriesforthesameindexfollowremarkableregularities.
Figure 1 shows the average age trajectories of selected
physiological indices evaluated from the data on the original
cohort of the Framingham Heart Study (FHS).
One can see from this ﬁgure that some indices tend to
change monotonically with age: the level of blood glucose
(BG) increases almost monotonically; the pulse pressure
(PP) increases from age 40 till age 85, then levels oﬀ and
shows a tendency to decline only at later ages. The age
trajectories of other indices are nonmonotonic: they tend to
increase ﬁrst and then decline. Physiological average body
mass index (BMI) increases up to about age 70 and then
declines, diastolic blood pressure (DBP) increases till age 55–
60 and then declines, serum cholesterol (SCH) increases till
age 50 in males, and till age 70 in females and then declines,
pulse rate (PR) increases till age 55 in males and till age 45 in
femalesandthendeclines,hematocrit(HC)declinesafterage
70inbothsexes.Withsmallvariations,thesegeneralpatterns
are similar in males and females.
Theeﬀectsof these indices on mortality risk were studied
in [1–3]. It was found that these eﬀects are gender and
age speciﬁc. The fact that the age dependence aﬀects the
shape of mortality risk function provided important insights
into the mechanisms by which aging process aﬀects the
decline in stress resistance in individuals [4–6]. It was also
found that dynamic properties of individual age trajectories
of physiological indices may diﬀer dramatically from one
individual to the next.
Researchers continue the debates about determinants of
the aging rate and about possible contribution of this rate to
life span and healthy life span [7–17]. Since the rate of aging
literally means the rate of changing with age, it would be
reasonable to assume that individual diﬀerences in the aging
rate are to be manifested in variability of dynamic properties
of individual age trajectories of physiological indices. And if2 Current Gerontology and Geriatrics Research
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Figure 1: Mean values (± s.e.) of physiological indices in participants of the original cohort of the Framingham Heart Study (pooled data
of available measurements from exams 1–25).
individual aging rate aﬀects life span and healthy life span
then one can expect that dynamic characteristics of such
trajectories will aﬀect morbidity and mortality risks.
A number of studies available in the literature support
the view about the importance of using dynamic properties
of individual age associated changes in physiological indices
as the characteristics of aging process that predict morbidity
and mortality risks, in addition to the use of the age-speciﬁc
baseline measurements [18–24].
In this paper we investigate the eﬀects of selected
parameters describing the dynamic properties of the age
trajectories of seven physiological indices on consequent
morbidity and mortality risks in participants of the FHS
original cohort.
2.DataandMethod
2.1. The Framingham Heart Study (FHS). The FHS Orig-
inal cohort was launched in 1948 (Exam 1), with 5,209
respondents (55% females) aged 28–62 years residing in
Framingham, Massachusetts, who had not yet developed
overt symptoms of cardiovascular disease, and continued to
the present with biennial examinations (29 exams to date,
data from exams 1–25 were used in this study) that include
detailed medical history, physical exams, and laboratory
tests.
2.2. Phenotypic Traits. Phenotypic traits collected in the
FHS cohorts over 60 years and relevant to our analysesCurrent Gerontology and Geriatrics Research 3
include life span, ages at onset of diseases (with the emphasis
on cardiovascular diseases (CVD), cancer, and diabetes
mellitus), as well as indices characterizing physiological
state. The occurrence of diseases (CVD and cancer) and
death has been followed through continuous surveillance
of hospital admissions, death registries, clinical exams, and
other sources, so that all the respective events are included in
the study. We used data on onset of CVD, cancer (calculated
from the followup data) and diabetes (deﬁned as the age at
theﬁrstexamwhenanindividualhasavalueofBGexceeding
140mg/dl and/or takes insulin and/or oral hypoglycemic
agent) to deﬁne the age at onset of “unhealthy life” as the
minimum of ages at onset of these three diseases. If an
individual did not contract any of these diseases during
the observation period than the individual was considered
censored at the age of the last followup or death. Individuals
who had any of the diseases before the ﬁrst FHS exam
were excluded from the analyses of “unhealthy life.” Data
on physiological indices include random blood glucose (BG,
exams1–4,6,8–10,13–23),bodymassindex(BMI,exams1–
25), diastolic blood pressure (DBP, exams 1–25), hematocrit
(HC, exams 4–21), pulse pressure (PP, exams 1–25), pulse
rate(PR,exams1,4–25),andserumcholesterol(SCH,exams
1–11, 13–15, 20, 22–25).
2.3. Deﬁnitions of “Dynamic” Risk Factors. We investigated
dynamic properties of individual age trajectories of seven
physiological indices mentioned above to select factors
(referred to as “dynamic” risk factors) capable of aﬀecting
mortality risk and risk of onset of “unhealthy life.” BG was
excluded from the list of indices for analyses of onset of
“unhealthylife”becauseintheFHSdatatheonsetofdiabetes
is speciﬁcally deﬁned from the values of BG.
First, we evaluated the eﬀect of the rate of changes
in physiological indices at ages 40–60 on mortality risk
and risk of onset of “unhealthy life” at ages 60+. For this
purpose, we approximated the individual trajectories of
thosephysiologicalindicesthathaveanearlylineardynamics
(both for females and males) at ages 40–60 (BG, BMI,
HC, and PP) by a linear function of the form y(x) =
a40−60 + b40−60(x − 40), where x is age and y is the value
of a physiological index at age x. Individuals having less
than 5 observations of respective index at ages 40–60 were
excluded from the analyses. As a result, we have estimates
of three risk factors for each individual and each index: an
initial value of an index at age 40 (i.e., a40−60,r e f e r r e dt o
as “Intercept40−60” in Tables 1 and 2 and the text below),
the rate of change in the physiological index at ages 40–
60 (b40−60,“ Slope40−60”), and the mean of absolute values
of residuals, that is, deviations of observed values of an
index from those approximated by a linear function at ages
40–60 (“Variability40−60”). The joint eﬀect of these risk
factors on mortality and incidence of “unhealthy life” was
estimated (separately for each physiological index) by the
Cox proportional hazards model with delayed entry (the left
truncation time was deﬁned as the maximum of the age at
the ﬁrst FHS exam and 60). Respectively, individuals with
ages at death (onset of “unhealthy life”)/censoring below 60
were excluded from the analyses. Note that although the use
of linear functions for describing individual aging-related
changes is a rough approximation of monotonic changes, it
captures important dynamic risk factor—the average rate of
change of individual index at the age interval between 40 and
60 years.
Second,weevaluatedtheeﬀectofdynamiccharacteristics
of physiological indices with nonmonotonic age trajectories
onmortalityriskandriskofonsetof“unhealthylife.”Forthis
purpose,weapproximatedtheagetrajectoriesofsuchindices
(BMI, DBP, HC, PR, and SCH) by two linear functions. The
ﬁrst one approximates the increase in the trajectory at the
initial interval [xL, xmax]: y(x) = aL + bL(x − xL), where
x is age and y is the value of a physiological index at age
x. The second one approximates the subsequent decline in
the trajectory at the interval [xmax, xR] after reaching the
maximumvalue ymax = aL+bL(xmax−xL)atagexmax: y(x) =
aR+bR(x−xmax).Theintervals[xL,xR]fortheﬁtweredeﬁned
empirically for each index and sex as follows: [35, 55] for
PR (females); [40, 60] for PR (males) and SCH (males);
[45, 65] for BMI (males) and DBP (females and males);
[50, 70] for SCH (females); [55, 75] for BMI (females) and
HC (females and males). Note that the following restrictions
on parameters were used in the estimation procedures: bL >
0, bR < 0, and aR = aL + bL(xmax − xL) to ensure the
appropriate shape of the ﬁt. Individuals having less than 6
observations of respective index at ages [xL − 5, xR +5 ]
and those having estimates of bL, bR at the boundary of
allowable values (i.e., nearly zero) were excluded from the
analyses. As a result, we have estimates of six risk factors
for each individual and each index: an initial value of an
index at age xL (i.e., aL,r e f e r r e dt oa s“ Intercept2L”i n
Tables 3 and 4 and the text below), the rate of increase
in the physiological index at ages [xL, xmax]( bL,“ Left
Slope”), the maximal value of the index approximated by two
linear functions describing increase and decline in respective
individual indices (ymax,“ Max Index”), age at reaching the
maximal value of the index (xmax,“ Age Max”), the rate of
decline in the index at ages [xmax, xR]( bR,“ Right Slope,”
see also Figure 2 for illustration), and the mean of absolute
values of residuals, that is, deviations of observed values of
an index from those approximated by two linear functions
at ages [xL, xR]( “ Variability2L”). The joint eﬀect of these
risk factors on mortality and incidence of “unhealthy life”
was estimated (separately for each physiological index) by
the Cox proportional hazards model with delayed entry (the
left truncation time was deﬁned as the maximum of the age
at the ﬁrst FHS exam and xR). Respectively, individuals with
ages at death (onset of “unhealthy life”)/censoring below xR
were excluded from the analyses. If xR is diﬀerent for females
and males for some index, then the maximum of the two
values was used in the (sex-adjusted) model applied to that
index. Note that all these calculations were performed for
individual age trajectories of respective indices. As a result,
each individual is now characterized by a vector of dynamic
parameters.
We also evaluated the empirical (Kaplan-Meier) esti-
mates of survival functions (and probabilities of staying
free of the diseases deﬁning the onset of “unhealthy life”)4 Current Gerontology and Geriatrics Research
for individuals with diﬀerent values of the dynamic risk
factors based on the indices with nonmonotonic trajecto-
ries (separately for females and males). For each physio-
logical index and each dynamic risk factor (“Age Max,”
“Max Index,”“ Intercept2L,” “Left Slope,”“ Right Slope,”a n d
“Variability2L”),wecalculatedthevaluesoftheriskfactorin
all eligible individuals from the sample using the procedure
described above. Then we evaluated the medians of such
empirical distributions of risk factors, separately for females
and males. These median values were used to deﬁne the sex-
speciﬁc strata for estimation of survival curves. We assigned
individuals of respective sex into one of two strata depending
on whether the value of the risk factor for this individual
is below (this stratum is denoted as “lower half” in Figures
3–6) or above (denoted as “upper half” in Figures 3–6) the
(sex-speciﬁc) median value. In case of an odd number of
individuals, the individual with the value of the risk factor
equal to the median was assigned to the upper stratum.
Then we calculated the Kaplan-Meier estimates of survival
curves (conditional at the sex- and index-speciﬁc ages xR)
for individuals in these two strata. Note that individuals with
ages at death (onset of “unhealthy life”)/censoring below
xR were excluded from the analyses, as described above.
Respective graphs are shown in Figures 3–6.F o re x a m p l e ,
the median value of the right slopes calculated for BMI in
females equals −0.103. Hence, individuals from the stratum
denoted as “lower half” in the upper left graph of Figure 3
are females with values of the right slope of BMI smaller
than −0.103. Individuals belonging to the stratum named
“upper half” in the upper left graph of Figure 3 are females
with values of the right slope of BMI larger than −0.103. The
conditional survival curves for the two strata presented in
this ﬁgure deal with individuals survived until age 75 years,
w h i c hi st h ev a l u eo fxR for BMI in females, as described
above.
2.4. Statistical Analyses. Statistical analyses and graphic out-
put were performed with SAS/STAT (SAS Institute Inc.) and
MATLAB (MathWorks Inc.) software packages. P values for
the regression parameters in the tables were calculated using
the Wald chi-square statistic with respect to a chi-square
distribution with one degree of freedom using SAS/STAT
PROC PHREG. The log-rank test was used to test the
null hypotheses about the equality of the empirical survival
curves in the strata. Respective P values are shown in
Figures 3–6 (SAS/STAT PROC LIFETEST was used for these
purposes).
3. Results
3.1. Eﬀect of Individual Dynamics of Physiological Indices at
Ages 40–60 on Mortality Risk and Risk of Onset of “Unhealthy
Life” at Ages 60+. As described in Section 2,w ee v a l u a t e d
the eﬀect of individual dynamics of physiological indices at
ages 40–60 on mortality risk and risk of onset of “unhealthy
life” at ages 60+ for those indices that have a nearly linear
pattern of change at the age interval 40–60 for both females
and males. Table 1 shows the estimates of the joint eﬀect
Estimated slopes
DBP
Age
Maximal
value
Age at maximum
Figure 2: Dynamic characteristics of a hypothetical non-
monotonically changing physiological index (denoted here “DBP”)
considered as potential risk factors: 1) Maximum value; 2) Age at
which the maximum has been reached; 3) Average rate of decline
after reaching the maximum. The ﬁgure illustrates evaluation of
average rates of decline in two individuals having the same pattern
of increase until reaching the maximum and diﬀerent patterns of
decline after reaching the maximum: a) the solid line for a rapidly
declining index and its approximation by a straight line; b) the
dottedlineforaslowlydecliningindexanditslinearapproximation.
The slopes of respective straight lines are considered as risk factors
for mortality and onset of “unhealthy life.”
of these risk factors on mortality as evaluated by the Cox
proportional hazards model. One can see from this table
that the variability around the average linear trajectory
(“Variability40−60”) and the average rate of change between
ages 40 and 60 (“Slope40−60”) are signiﬁcant risk factors for
mortality for all indices. The signiﬁcance is highest (P<
.0001) for the slopes of HC and PP. The initial value of an
index at age 40 (“Intercept40−60”) is also a highly signiﬁcant
(P<. 0001) risk factor for mortality for HC and PP (i.e.,
higher values of respective index at age 40 correspond to
higher risk of death compared to smaller values of this
index), being nonsigniﬁcant for BG.
The eﬀect of these dynamic characteristics on incidence
of “unhealthy life” is similar (see Table 2). However, the
variability is signiﬁcant only for PP. Note that the eﬀect
of variable “Sex” on both mortality and risk of onset of
“unhealthy life” is signiﬁcant and that the risk for males is
higher than those for females.
3.2. Eﬀect of Dynamic Characteristics of Physiological Indices
with Nonmonotonic Age Trajectories on Mortality Risk and
Risk of Onset of “Unhealthy Life”. For indices with non-
monotonic age trajectories, we evaluated the maximum
value of respective index, age at which this maximum is
reached, the intercept, and the left and right slopes of the
linear functions approximating the increase and decline of
respective indices as described in Section 2. Tables 3 and 4
show the estimates of the joint eﬀect of these risk factors
on mortality and incidence of “unhealthy life” as evaluated
by the Cox proportional hazards model. One can see fromCurrent Gerontology and Geriatrics Research 5
Table 1: Eﬀect of “dynamic” risk factors calculated from individual trajectories of physiological indices at ages 40–60 on mortality risk at
ages 60+ in the Framingham Heart Study (original cohort) estimated by the Cox proportional hazards model.
Physiological Index Risk Factor (RF) Mean RF (St. Dev.) Cox Regression Model
Parameter (S.E.) Hazard Ratio (95% C.I.)
BG
(N = 2224,
Ne = 1447,
Nc = 777)
Intercept40−60 77.468 (20.370) 0.003 (0.002) 1.056 (0.978, 1.140)
Slope40−60 0.553 (1.932) 0.059
∗ (0.029) 1.088 (1.002, 1.182)
Variability40−60 8.518 (6.798) 0.017# (0.005) 1.086 (1.033, 1.141)
Sex 0.581
† (0.053) 1.789 (1.611, 1.985)
BMI
(N = 3150,
Ne = 2217,
Nc = 933)
Intercept40−60 25.867 (4.215) 0.016# (0.006) 1.086 (1.020, 1.157)
Slope40−60 0.050 (0.171) −0.305
∗ (0.141) 0.945 (0.897, 0.995)
Variability40−60 0.697 (0.392) 0.176# (0.060) 1.074 (1.024, 1.126)
Sex 0.564
† (0.045) 1.757 (1.610, 1.918)
HC
(N = 2167,
Ne = 1323,
Nc = 844)
Intercept40−60 45.341 (4.664) 0.086
† (0.011) 1.622 (1.430, 1.839)
Slope40−60 −0.026 (0.272) 0.932
† (0.172) 1.311 (1.189, 1.446)
Variability40−60 1.548 (0.633) 0.089
∗ (0.044) 1.073 (1.002, 1.148)
Sex 0.255
§ (0.071) 1.291 (1.123, 1.484)
PP
(N = 3153,
Ne = 2219,
Nc = 934)
Intercept40−60 44.112 (13.095) 0.024
† (0.002) 1.349 (1.273, 1.428)
Slope40−60 0.506 (0.846) 0.338
† (0.035) 1.360 (1.277, 1.448)
Variability40−60 4.815 (2.032) 0.036# (0.012) 1.090 (1.033, 1.150)
Sex 0.611
† (0.044) 1.842 (1.691, 2.007)
Notes. ∗.01 ≤ P<. 05, #.001 ≤ P<. 01, §.0001 ≤ P<. 001, †P<. 0001, for other estimates: P ≥ .05; Sex: 1—male, 0—female; the other Risk Factors
are continuous and calculated as described in Section 2; N denotes the total number of individuals; Ne is the total number of events (deaths); Nc is the
total number of censored individuals; Hazard Ratios for continuous risk factors are for an increase from the ﬁrst quartile to the third quartile of respective
empirical distributions.
Table 2: Eﬀect of “dynamic” risk factors calculated from individual trajectories of physiological indices at ages 40–60 on risk of onset of
“unhealthy life” at ages 60+ in the Framingham Heart Study (original cohort) estimated by the Cox proportional hazards model.
Physiological Index Risk Factor (RF) Mean RF (St. Dev.) Cox Regression Model
Parameter (S.E.) Hazard Ratio (95% C.I.)
BMI
(N = 2458,
Ne = 1824,
Nc = 634)
Intercept40−60 25.587 (3.954) 0.036
† (0.007) 1.198 (1.119, 1.283)
Slope40−60 0.057 (0.162) 0.609
§ (0.159) 1.116 (1.055, 1.180)
Variability40−60 0.679 (0.381) 0.013 (0.070) 1.005 (0.953, 1.060)
Sex 0.511
† (0.049) 1.668 (1.513, 1.837)
HC
(N = 1659,
Ne = 1192,
Nc = 467)
Intercept40−60 45.044 (4.641) 0.078
† (0.012) 1.556 (1.365, 1.774)
Slope40−60 −0.021 (0.269) 1.140
† (0.182) 1.384 (1.250, 1.533)
Variability40−60 1.547 (0.635) 0.082 (0.046) 1.069 (0.993, 1.150)
Sex 0.287
† (0.073) 1.332 (1.155, 1.536)
PP
(N = 2460,
Ne = 1825,
Nc = 635)
Intercept40−60 43.612 (12.635) 0.018
† (0.003) 1.249 (1.170, 1.334)
Slope40−60 0.480 (0.814) 0.319
† (0.040) 1.325 (1.237, 1.420)
Variability40−60 4.667 (1.944) 0.046
§ (0.014) 1.111 (1.046, 1.181)
Sex 0.577
† (0.048) 1.781 (1.622, 1.957)
Notes. ∗.01 ≤ P<. 05, #.001 ≤ P<. 01, §.0001 ≤ P<. 001, †P<. 0001, for other estimates: P ≥ .05; Sex: 1—male, 0—female; the other Risk Factors are
continuous and calculated as described in Section 2; N denotes the total number of individuals; Ne is the total number of events (onset of “unhealthy life”);
Nc is the total number of censored individuals; Hazard Ratios for continuous risk factors are for an increase from the ﬁrst quartile to the third quartile of
respective empirical distributions.
Table 3 that the eﬀect of the rate of decline in the index
after reaching the maximum (“Right Slope”) on mortality
risk is signiﬁcant for all indices (the highest signiﬁcance,
P<. 0001, is observed for BMI and DBP). In this case,
the faster decline in the index after reaching the maximum
corresponds to a signiﬁcant increase in mortality risk (note
that the values of “Right Slope” are negative by deﬁnition, see
Section 2). On the contrary, the rate of increase in the index
before reaching the maximum (“Left Slope”) and the initial
value from which the increase has started (“Intercept2L”)
are not signiﬁcant risk factors for mortality for any index.
The estimated maximal value of the index reached is also a6 Current Gerontology and Geriatrics Research
Table 3: Eﬀect of “dynamic” risk factors calculated from individual trajectories of physiological indices with nonmonotonic patterns on
mortality risk in the Framingham Heart Study (original cohort) estimated by the Cox proportional hazards model.
Physiological Index Risk Factor (RF) Mean RF (St. Dev.) Cox Regression Model
Parameter (S.E.) Hazard Ratio (95% C.I.)
BMI
(N = 2686,
Ne = 1824,
Nc = 862)
Age Max 62.063 (8.762) −0.001 (0.004) 0.983 (0.887, 1.089)
Max Index 27.869 (4.392) −0.001 (0.012) 0.997 (0.884, 1.124)
Intercept2L 26.171 (4.187) 0.007 (0.012) 1.034 (0.925, 1.156)
Left Slope 0.220 (0.505) −0.017 (0.049) 0.996 (0.975, 1.018)
Right Slope −0.224 (0.576) −0.177
† (0.025) 0.959 (0.948, 0.970)
Variability2L 0.729 (0.371) 0.356
† (0.073) 1.153 (1.088, 1.221)
Sex 0.561
† (0.064) 1.753 (1.545, 1.989)
DBP
(N = 3133,
Ne = 2242,
Nc = 891)
Age Max 55.165 (6.973) −0.008
∗ (0.004) 0.903 (0.822, 0.992)
Max Index 86.804 (10.465) 0.016
† (0.003) 1.245 (1.141, 1.358)
Intercept2L 80.471 (12.962) 0.001 (0.003) 1.008 (0.942, 1.079)
Left Slope 0.842 (1.439) 0.006 (0.021) 1.006 (0.966, 1.047)
Right Slope −0.988 (1.976) −0.055
† (0.010) 0.939 (0.918, 0.961)
Variability2L 3.984 (1.383) 0.096
† (0.016) 1.172 (1.114, 1.233)
Sex 0.514
† (0.043) 1.671 (1.536, 1.818)
HC
(N = 2471,
Ne = 1650,
Nc = 821)
Age Max 66.061 (7.020) −0.009
∗ (0.004) 0.882 (0.795, 0.978)
Max Index 46.567 (3.265) 0.024
∗ (0.012) 1.108 (1.003, 1.224)
Intercept2L 43.756 (4.848) 0.007 (0.008) 1.031 (0.960, 1.108)
Left Slope 0.390 (0.733) −0.011 (0.054) 0.996 (0.956, 1.037)
Right Slope −0.856 (3.533) −0.018
∗ (0.007) 0.988 (0.979, 0.997)
Variability2L 1.472 (0.551) 0.099
∗ (0.045) 1.066 (1.006, 1.129)
Sex 0.398
† (0.060) 1.488 (1.323, 1.675)
PR
(N = 1847,
Ne = 1097,
Nc = 750)
Age Max 47.279 (7.676) −0.012
∗ (0.005) 0.851 (0.742, 0.977)
Max Index 81.206 (10.689) 0.016
† (0.004) 1.247 (1.126, 1.381)
Intercept2L 71.554 (15.226) −0.002 (0.003) 0.979 (0.904, 1.059)
Left Slope 1.535 (3.445) 0.007 (0.013) 1.011 (0.972, 1.052)
Right Slope −0.898 (1.980) −0.070
§ (0.021) 0.927 (0.886, 0.970)
Variability2L 5.057 (1.978) 0.028 (0.017) 1.070 (0.988, 1.159)
Sex 0.727
† (0.070) 2.069 (1.804, 2.374)
SCH
(N = 2297,
Ne = 1711,
Nc = 586)
Age Max 55.574 (8.298) 0.002 (0.005) 1.023 (0.923, 1.134)
Max Index 261.965 (42.429) 0.001 (0.001) 1.059 (0.958, 1.170)
Intercept2L 225.428 (61.457) −0.0003 (0.001) 0.981 (0.903, 1.066)
Left Slope 5.517 (8.442) −0.005 (0.005) 0.975 (0.921, 1.032)
Right Slope −4.121 (8.689) −0.007
∗ (0.003) 0.969 (0.946, 0.993)
Variability2L 13.484 (6.237) 0.014# (0.004) 1.101 (1.039, 1.166)
Sex 0.566
† (0.073) 1.761 (1.526, 2.031)
Notes. ∗.01 ≤ P<. 05, #.001 ≤ P<. 01, §.0001 ≤ P<. 001, †P<. 0001, for other estimates: P ≥ .05; Sex: 1—male, 0—female; the other Risk Factors
are continuous and calculated as described in Section 2; N denotes the total number of individuals; Ne is the total number of events (deaths); Nc is the
total number of censored individuals; Hazard Ratios for continuous risk factors are for an increase from the ﬁrst quartile to the third quartile of respective
empirical distributions.
signiﬁcant risk factor for mortality in case of DBP, PR (both
have P<. 0001), and HC (P<. 05). This means that the
larger (sex-adjusted) maximal values of respective indices
(reached at “Age Max”) correspond to a signiﬁcant increase
in mortality risk. The age at reaching the maximum is itself
a signiﬁcant risk factor for mortality for these indices. The
negative values of respective estimates indicate that the later
an individual reaches the maximum, the smaller mortality
risk is. The variability in all indices except PR signiﬁcantly
aﬀects mortality risks (the larger variability corresponds to
higher mortality risks).
The eﬀect of these dynamic characteristics on risk of
onset of “unhealthy life” is less pronounced than that on
mortality risks. Table 4 shows that the rate of decline afterCurrent Gerontology and Geriatrics Research 7
Table 4: Eﬀect of “dynamic” risk factors calculated from individual trajectories of physiological indices with nonmonotonic patterns on risk
of onset of “unhealthy life” in the Framingham Heart Study (original cohort) estimated by the Cox proportional hazards model.
Physiological Index Risk Factor (RF) Mean RF (St. Dev.) iCox Regression Model
Parameter (S.E.) Hazard Ratio (95% C.I.)
BMI
(N = 1380,
Ne = 782,
Nc = 598)
Age Max 63.199 (8.535) 0.012 (0.006) 1.189 (0.997, 1.417)
Max Index 27.383 (4.016) −0.011 (0.024) 0.947 (0.757, 1.186)
Intercept2L 25.696 (3.875) 0.037 (0.025) 1.184 (0.954, 1.469)
Left Slope 0.194 (0.350) 0.340
∗ (0.155) 1.073 (1.007, 1.143)
Right Slope −0.235 (0.801) −0.041 (0.044) 0.991 (0.972, 1.011)
Variability2L 0.703 (0.359) −0.007 (0.121) 0.997 (0.910, 1.092)
Sex 0.497
† (0.102) 1.644 (1.346, 2.009)
DBP
(N = 2139,
Ne = 1512,
Nc = 627)
Age Max 55.325 (7.112) −0.006 (0.004) 0.926 (0.827, 1.037)
Max Index 85.806 (9.966) 0.017
† (0.004) 1.239 (1.129, 1.360)
Intercept2L 79.309 (12.066) 0.001 (0.003) 1.013 (0.940, 1.093)
Left Slope 0.912 (1.808) 0.009 (0.017) 1.008 (0.978, 1.040)
Right Slope −0.980 (2.390) −0.014 (0.009) 0.986 (0.968, 1.004)
Variability2L 3.850 (1.311) 0.039 (0.020) 1.064 (0.999, 1.133)
Sex 0.488
† (0.053) 1.629 (1.470, 1.806)
HC
(N = 1254,
Ne = 705,
Nc = 549)
Age Max 66.094 (7.125) −0.011 (0.006) 0.863 (0.732, 1.017)
Max Index 46.088 (3.141) 0.028 (0.018) 1.129 (0.967, 1.319)
Intercept2L 43.417 (3.810) −0.002 (0.016) 0.990 (0.868, 1.130)
Left Slope 0.372 (0.713) −0.041 (0.078) 0.985 (0.933, 1.041)
Right Slope −0.775 (2.966) 0.0002 (0.013) 1.000 (0.985, 1.016)
Variability2L 1.442 (0.534) 0.033 (0.074) 1.021 (0.930, 1.122)
Sex 0.363
† (0.091) 1.438 (1.203, 1.718)
PR
(N = 1401,
Ne = 1013,
Nc = 388)
Age Max 47.167 (7.589) 0.004 (0.005) 1.057 (0.921, 1.213)
Max Index 80.449 (10.535) 0.009
∗ (0.004) 1.129 (1.011, 1.262)
Intercept2L 71.162 (13.289) −0.001 (0.004) 0.987 (0.893, 1.091)
Left Slope 1.443 (3.034) 0.007 (0.013) 1.010 (0.973, 1.049)
Right Slope −0.850 (1.650) 0.013 (0.023) 1.014 (0.968, 1.062)
Variability2L 4.954 (1.936) −0.002 (0.018) 0.994 (0.913, 1.082)
Sex 0.569
† (0.070) 1.766 (1.539, 2.025)
SCH
(N = 1361,
Ne = 913,
Nc = 448)
Age Max 56.821 (8.200) 0.005 (0.006) 1.063 (0.908, 1.245)
Max Index 261.843 (42.286) 0.002 (0.001) 1.120 (0.978, 1.282)
Intercept2L 225.919 (62.186) −0.001 (0.001) 0.943 (0.854, 1.040)
Left Slope 5.147 (8.013) 0.002 (0.007) 1.012 (0.936, 1.095)
Right Slope −4.329 (9.443) −0.004 (0.004) 0.984 (0.952, 1.017)
Variability2L 13.452 (6.246) 0.010 (0.006) 1.070 (0.986, 1.161)
Sex 0.595
† (0.097) 1.813 (1.499, 2.192)
Notes. ∗0.01 ≤ P<. 05, #.001 ≤ P<. 01, §.0001 ≤ P<. 001, †P<. 0001, for other estimates: P ≥ .05; Sex: 1—male, 0—female; the other Risk Factors are
continuous and calculated as described in Section 2; N denotes the total number of individuals; Ne is the total number of events (onset of “unhealthy life”);
Nc is the total number of censored individuals; Hazard Ratios for continuous risk factors are for an increase from the ﬁrst quartile to the third quartile of
respective empirical distributions.
reaching the maximum (“Right Slope”), age at reaching
the maximum (“Age Max”), and the variability become
nonsigniﬁcant for all indices. The maximal value reached is
signiﬁcant only for DBP (P<. 0001) and PR (P<. 05).
The rate of increase of BMI before reaching the maximum
becomes signiﬁcant (P<. 05), with the faster rate of increase
corresponding to a higher risk of onset of “unhealthy life.”
Note again that the eﬀect of variable “Sex” on both mortality
andriskofonsetof“unhealthylife”issigniﬁcantandthatthe
risk for males is higher than that for females.
3.3. Eﬀect of Dichotomized Dynamic Characteristics of Physi-
ological Indices with Nonmonotonic Age Trajectories. We also
evaluated the Kaplan-Meier estimates of survival functions
for individuals with diﬀerent values of the dynamic risk8 Current Gerontology and Geriatrics Research
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Figure 3: : Kaplan-Meier estimates of survival functions for females (a) and males (b) having the average rate of decline of diﬀerent
physiological indices after reaching the maximum (“right slope,” see Section 2) from the lower and upper halves of empirical distributions of
thisriskfactorforrespectiveindices;P denotesP valueforthenullhypothesesabouttheequalityofthesurvivalcurvesinthestrataevaluated
by the log-rank test.
factors based on the indices with nonmonotonic trajectories
dividing the entire sex-speciﬁc samples into strata represent-
ing individuals with the values of the index in the lower and
upper halves of the empirical distribution of respective index
(see Section 2).
Figure 3 shows the estimates of survival functions for
females and males having the average rate of decline of
diﬀerent physiological indices after reaching the maximum
(“Right Slope”) from the lower and upper halves of empirical
distributions of this risk factor for respective indices. One
can see from this ﬁgure that the lower absolute values of
the slope (i.e., the lower rates of the postmaximum decline)
in individuals from the upper half of the distribution are
associated with better survival for all indices except SCH for
females (nonsigniﬁcant results for PR for both sexes are not
shown). The highest signiﬁcance (P<. 0001) is observed for
BMI in females and SCH in males.
Figure 4 illustrates similar estimates in case of “vari-
ability” of diﬀerent physiological indices (the mean of
absolute values of residuals, that is, deviations of observed
values of an index from those approximated by two linear
functions at respective age intervals, see Section 2). The
higher “variability” of trajectories of BMI, DBP, and SCH at
respective age intervals in individuals from the upper half of
the distribution result in worse survival for both females and
males (nonsigniﬁcant results for HC and PR are not shown).
The highest signiﬁcance (P<. 0001) is observed for DBP in
both females and males.
Later ages at reaching the maximal value of DBP and
PR in females from the upper half of the distribution are
associated with better survival (Figure 5), however this was
notobservedformales.Thehigherestimatedmaximalvalues
of these indices in individuals from the upper half of the
distribution correspond to worse survival for both females
and males. All other indices did not produce any signiﬁcant
results and are not shown in Figure 5.
Similar calculations for probabilities of staying free of the
diseasesdeﬁningtheonsetof“unhealthylife”revealedamore
mosaicpicture.Themostconsistentresultswereobservedfor
DBP (Figure 6).
The higher initial values of DBP at age 45 and the higher
estimated values of DBP reached in individuals from the
upper halves of respective distributions are associated with
worse chances of staying free of the “unhealthy life,” for
both sexes. The lower rates of the postmaximum decline
of DBP in females, but not males, from the upper half
of the distribution correspond to better chances of staying
free of the “unhealthy life” (Figure 6). In addition, earlier
ages at reaching the maximum of SCH for females (P =
.008), the smaller estimated maximal values of BMI (P =
.005) and HC (P = .02) for females, and PR (P = .001)
and SCH (P = .017) for males, and a smaller initial
value of BMI at age 55 (P = .001) for females and a
smaller initial value of SCH at age 40 (P = .0004) for
males, were related to better chances of staying free of the
“unhealthy life.”Current Gerontology and Geriatrics Research 9
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Figure 4: Kaplan-Meier estimates of survival functions for females (a) and males (b) having “variability” of diﬀerent physiological indices
(the mean of absolute values of residuals, i.e., deviations of observed values of an index from those approximated by two linear functions at
respective age intervals, see Section 2) from the lower and upper halves of empirical distributions of this risk factor for respective indices; P
denotes P value for the null hypotheses about the equality of the survival curves in the strata evaluated by the log-rank test.
3.4. Sensitivity Analyses. We should note that the question
about the eﬀect of the quality of estimates is important
given that at most 11 observations for the monotone indices
or 15 observations for non-monotone indices were used
(note that for non-monotone indices data from 30-year
intervals [xL − 5, xR + 5], where xR − xL = 20, were used
for calculating dynamic risk factors). These observations
were used to estimate two parameters (those of the linear
regression) for monotone indices and four parameters (age
at reaching the maximal value of the index, intercept, and
two slopes) for non-monotone indices. To partly reduce the
eﬀect of a poor ﬁt due to a small number of longitudinal
observations, we removed those individuals having less than
5 (less than 6 for non-monotone indices) observations from
analyses. Clearly, the results could change had we used
diﬀerent numbers for the minimal allowable numbers of
observations. To test how sensitive our results are to such
changes, we performed sensitivity analyses with diﬀerent
minimal allowable numbers of observations: 4, 6, and 7
for monotone indices, and 5, 7, and 8 for non-monotone
ones. The results showed that the eﬀect of dynamic risk
factors calculated from individual trajectories of monotone
indices at ages 40–60 on mortality risk and risk of onset of
“unhealthy life” at ages 60+ is stable across diﬀerent studies.
All risk factors for which the estimates of the regression
parameters were signiﬁcant (P<. 01) in the original study,
exhibited similar signiﬁcant eﬀects on mortality risk or risk
ofonsetof“unhealthylife”intheotherstudies.Despitesome
variability in the values of the estimates across the studies,
the “direction” of the eﬀect (i.e., the sign of the estimate)
was the same in all such cases. In the sensitivity analysis
with the largest cutoﬀ value, the P values were somewhat
larger in some cases which may be explained by a smaller
sample size compared to the original study. The eﬀects of
dynamic risk factors calculated from individual trajectories
of physiological indices with nonmonotonic patterns on
mortality risk and risk of onset of “unhealthy life” showed
similar stability across the studies as the monotone indices.
In all cases (except for the right slope of PR which appeared
either marginally signiﬁcant or nonsigniﬁcant in the other
studies), risk factors for which the estimates of the regression
parameters were signiﬁcant (P<. 01) in the original study
exhibited similar signiﬁcant eﬀects on mortality risk or risk
of onset of “unhealthy life” in other studies. The same
observation regarding the sensitivity analysis based on the
largest cutoﬀ value was true for non-monotone risk factors
too.
4. Discussion
An increase in mortality rate with age is traditionally asso-
ciated with progressing aging. This inﬂuence is mediated by
the aging-associated changes in thousands of biological and10 Current Gerontology and Geriatrics Research
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Figure 5:Kaplan-Meierestimatesofsurvivalfunctionsforfemales(a)andmales(b)havingagesatreachingthemaximumandtheestimated
maximal value (see Section 2)o fd i ﬀerent physiological indices from the lower and upper halves of empirical distributions of these risk
factors for respective indices; P denotes P value for the null hypotheses about the equality of the survival curves in the strata evaluated by the
log-rank test.
physiological variables, some of which have been measured
in aging studies. The fact that the age trajectories of some
of such variables diﬀer among individuals with short and
long life spans and healthy life spans indicates that dynamic
properties of respective indices aﬀect the life history traits.
Our analyses of the FHS data clearly demonstrate that the
values of physiological indices at age 40 are signiﬁcant
contributors to both life span and healthy life span (as
show the estimates of Intercept40−60 in Tables 1 and 2),
suggesting that normalizing these variables around the age
40 is important for preventing age-associated morbidity and
mortality later in life. Two dynamic parameters, Slope40−60
and Variability40−60, also have signiﬁcant eﬀect on mortality
risk (the former being more important predictor in case
of healthy life span). These data suggest that keeping
physiological indices stable over the years of life could be
as important as their normalizing around the age 40. Thus,
a slower change in an index with age is likely to indicate
the slower aging and the lower morbidity and mortality
risks.
Table 3 shows that dynamic properties of the indices that
change nonmonotonically with age signiﬁcantly contribute
to mortality risks and further demonstrates the importance
of maintaining stability of physiological state in aging
humans: the lower rate of decline in an index after reaching
the age at maximum means the more beneﬁcial eﬀect on all-
cause mortality.
The fact that the eﬀect of the studied dynamic char-
acteristics on risks of “unhealthy life” onset (Table 4)i s
less pronounced than that on all-cause mortality risk may
indicate that the dynamic characteristics reﬂect basic aging-
related processes in body that result in increasing nonspeciﬁc
vulnerability to death with age rather than in increasing
vulnerability to a particular pathology.
The review of the literature (below) supports our
ﬁndings with respect to importance of taking into account
longitudinal changes in physiological indices when evalu-
ating/predicting morbidity and mortality risks. One should
note, however, that the impact and comparative contri-
butions of dynamic parameters (left and right slopes,
variability, intercept) on mortality risks were evaluated in
our study for the ﬁrst time. In our two recent publications
we demonstrated that individuals who have diﬀerent rates
of aging related changes in BG levels also diﬀer in longevity
[2, 3].
The eﬀects of aging associated changes in serum choles-
terol on coronary and all-cause mortality were evaluated in
Finnish Cohorts of the Seven Countries study [22]. Men
with greatest declines in the cholesterol levels had increased
cardiovascular and all-cause mortality compared with men
with least change in the levels. In the Paris Prospective
Study [23], it was shown that not only a low baseline total
cholesterol level but also its decline over time was associated
with a higher cancer mortality.Current Gerontology and Geriatrics Research 11
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Figure 6: Kaplan-Meier estimates of probabilities of staying free of the diseases deﬁning the onset of “unhealthy life” for females (a) and
males (b) having initial values of diastolic blood pressure (DBP) at age 65, the estimated maximal values of DBP, and the average rates of
decline of DBP after reaching the maximum (“intercept,” “maximum,” and “right slope,” respectively, see Section 2) from the lower and
upper halves of empirical distributions of these risk factors; P denotes P value for the null hypotheses about the equality of the survival
curves in the strata evaluated by the log-rank test.
Similar to SCH, high blood pressure (BP) is a major
risk factor for CVD. A study of two independent French
male cohorts suggested that longitudinal changes in systolic
and diastolic BP may be more accurate determinants of
cardiovascular risks than baseline BP measures. In both
cohorts, the group with a long-term increase in systolic
and a decrease in diastolic BP (i.e., with increase in pulse
pressure)hadthehighest relativeriskofmortality fromCVD
compared to the group with no changes in either systolic
or diastolic BP, independently of absolute values of BP or
other risk factors [25]. Since this study included only males,
it is important to note that changes in pulse pressure may
in principle have diﬀerent eﬀects on mortality risks in males
and females [26, 27].
The heart rate (HR) is one more index characterizing
functioningofcardiovascularsystem.Prognosticimportance
of its baseline values as well as variability during 24-hour
HR monitoring in patients with heart disease and in general
population is recognized [28–30]. Contrarily, the prognostic
role of the long-term and age-related dynamics of HR is not
suﬃciently investigated and respective studies are limited.
Ar e c e n ts t u d yo ft h ee ﬀects of HR at baseline, ﬁnal HR,
and HR change during followup, on survival of patients
attending the Glasgow Blood Pressure Clinic revealed that
the highest risk of all-cause mortality was in patients who
had increased their HR by ≥5bpm at the end of followup,
as compared with those who had a consistently high (high-
high) or low (low-low) HR. Authors concluded that change
in HR during the followup is a better predictor of mortality
risk in hypertensive patients than baseline or ﬁnal HR [31].
The body mass index (BMI) is, probably, the most
intensively studied index in connection with health and
survival. Over recent decades, many studies addressed the
eﬀect of BMI dynamics on morbidity and mortality, espe-
cially the eﬀect of losing body weight in overweight/obese
individuals on risk factors for CVD and diabetes. It was
shown that overweight adults who lost weight over 9 years
had more favorable (lower) total and LDL cholesterol levels
compared to normal-weight control, but less favorable BG
levels [32]. In other studies weight loss was associated
with excess mortality when compared with weight stability,
even when controlled for confounding due to diseases
known to cause both weight loss and increased mortality
[33, 34].
It was also shown that the weight stability was associated
with a lower mortality risk as compared with weight change
(gain or loss) [35, 36]. Nilsson et al. [37], showed that in
men with decreasing BMI during 16 years of followup the
noncancer mortality was higher compared to BMI-stable
men. Authors hypothesized that involuntary weight loss in12 Current Gerontology and Geriatrics Research
otherwise healthy people could be a sign of premature aging,
which in turn caused a nonspeciﬁc increase in mortality
risk. In other studies, baseline weight and weight change
had independent eﬀects on total mortality, with both the
associations exhibiting a U-shaped relation [38, 39].
Note that the seven physiological indices used in this
paper do not exhaust the list of all possible physiological
risk factors for mortality and morbidity. Therefore, the
dynamic characteristics calculated from these seven indices
cannot explain the entire variability in human life span
and healthy life span. Other indices and risk factors can be
exploredontheirassociationwithmortality/morbidityriskif
measurements of such indices are available in a longitudinal
study for a substantially long-time period. See for example
[40] where midlife risk factors were investigated for a cohort
of Japanese American men with 40 years follow up.
5. Conclusion
In sum, our results indicate that the dynamic character-
istics of age-related changes in physiological variables are
important predictors of morbidity and mortality risks in
the aging individuals. Previously published epidemiological
ﬁndings are generally in concert with our results, which
clearly indicates the need for further detailed studies of
the dynamic parameters of aging related changes in human
body with further application of these principles to the
prevention strategies. We showed that the rate of changes in
physiologicalstateattheageintervalbetween40and60years
may serve as a good predictor of morbidity and mortality
risks later in life. For nonmonotonically changing indices,
theratesofdeclineafterreachingthemaximum,themaximal
values,andtheageatthemaximumareimportantpredictors
of morbidity and mortality risks.
Senescence is likely to be the key player in physiological
and biological changes observed in aging humans. The
dynamic properties of these changes contain important
information about the individual aging processes. This
information, however, can be masked by the eﬀects of
compensatory adaptation and remodeling developing in
responsetotheprimaryagingprocess.Studyingmechanisms
of such adaptation and its connection to morbidity and
mortality risks is important for better understanding factors
and mechanisms aﬀecting long and healthy life.
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